ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,790Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 559

$438K Total Retail Price of All Prescriptions

Rank: 51 out of 559

541 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,944 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
SIMVASTATIN 398 347 1 3
LEVOTHYROXINE SODIUM 335 280 2 2
HYDROCODONE-ACETAMINOPHEN 250 231 S3 3 7
AMLODIPINE BESYLATE 250 236 3 6
LISINOPRIL 231 199 5 1
OMEPRAZOLE 202 178 6 4
FLUTICASONE PROPIONATE 150 135 7 22
METFORMIN HCL 138 123 8 5
ATORVASTATIN CALCIUM 137 120 9 20
TRIAMTERENE-HCTZ 126 126 10 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 120 11 18
ZOLPIDEM TARTRATE 122 104 11 17
LOSARTAN POTASSIUM 118 110 13 14
ALENDRONATE SODIUM 115 108 14 13
HYDROCHLOROTHIAZIDE 108 107 15 8
PAROXETINE HCL 97 97 16 48
CITALOPRAM HBR 94 62 17 21
SYNTHROID 82 78 18 64
TAMSULOSIN HCL 80 80 19 25
DIOVAN 77 74 20 55
ATENOLOL 76 66 21 15
TRAZODONE HCL 71 57 22 28
METOPROLOL TARTRATE 70 65 23 12
LOSARTAN-HYDROCHLOROTHIAZIDE 67 63 24 52
METOPROLOL SUCCINATE 66 66 25 16
PROAIR HFA 63 52 26 29
FUROSEMIDE 62 58 27 11
RANITIDINE HCL 59 41 28 26
SPIRIVA 59 45 28 67
ADVAIR DISKUS 58 44 30 46
DONEPEZIL HCL 53 53 31 36
AZITHROMYCIN 52 44 32 39
GLYBURIDE 52 49 R 32 45
TRIAMCINOLONE ACETONIDE 52 47 32 84
CARVEDILOL 50 41 35 38
DIOVAN HCT 50 42 35 134
POTASSIUM CHLORIDE 50 50 35 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.